Drug-induced lipodystrophy: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Drug-induced lipodystrophy | |||
| synonyms = | |||
| field = [[Endocrinology]] | |||
| symptoms = [[Fat redistribution]], [[insulin resistance]], [[dyslipidemia]] | |||
| complications = [[Cardiovascular disease]], [[diabetes mellitus]] | |||
| onset = Varies depending on drug exposure | |||
| duration = May be reversible upon discontinuation of the drug | |||
| causes = [[Antiretroviral therapy]], [[glucocorticoids]], [[anabolic steroids]] | |||
| risks = Long-term use of certain medications | |||
| diagnosis = Clinical evaluation, [[medical history]], [[physical examination]] | |||
| differential = [[Congenital lipodystrophy]], [[acquired lipodystrophy]] | |||
| prevention = Monitoring and adjusting medication regimens | |||
| treatment = Discontinuation or substitution of the causative drug, [[dietary management]], [[exercise]], [[metformin]] | |||
| prognosis = Variable, depends on the ability to manage underlying causes | |||
| frequency = Common in patients on long-term antiretroviral therapy | |||
}} | |||
'''Drug-induced lipodystrophy''' is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. A side effect of some [[pharmaceutical drugs]], it is a form of [[lipodystrophy]] and can be a significant adverse effect of treatment. | '''Drug-induced lipodystrophy''' is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. A side effect of some [[pharmaceutical drugs]], it is a form of [[lipodystrophy]] and can be a significant adverse effect of treatment. | ||
== Causes == | == Causes == | ||
Drug-induced lipodystrophy can be caused by a number of drugs. These include [[insulin]], [[protease inhibitors]], [[glucocorticoids]], and [[growth hormone]] therapy. The condition is most commonly associated with [[antiretroviral therapy]] for [[HIV]]. | Drug-induced lipodystrophy can be caused by a number of drugs. These include [[insulin]], [[protease inhibitors]], [[glucocorticoids]], and [[growth hormone]] therapy. The condition is most commonly associated with [[antiretroviral therapy]] for [[HIV]]. | ||
== Symptoms == | == Symptoms == | ||
The symptoms of drug-induced lipodystrophy can vary depending on the specific drug and the individual patient. However, common symptoms include lipoatrophy (loss of subcutaneous fat), lipohypertrophy (gain of subcutaneous fat), and metabolic complications such as [[insulin resistance]], [[dyslipidemia]], and [[diabetes mellitus]]. | The symptoms of drug-induced lipodystrophy can vary depending on the specific drug and the individual patient. However, common symptoms include lipoatrophy (loss of subcutaneous fat), lipohypertrophy (gain of subcutaneous fat), and metabolic complications such as [[insulin resistance]], [[dyslipidemia]], and [[diabetes mellitus]]. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of drug-induced lipodystrophy is primarily based on the patient's medical history and physical examination. Laboratory tests may be used to confirm the diagnosis and assess the severity of the condition. | Diagnosis of drug-induced lipodystrophy is primarily based on the patient's medical history and physical examination. Laboratory tests may be used to confirm the diagnosis and assess the severity of the condition. | ||
== Treatment == | == Treatment == | ||
Treatment for drug-induced lipodystrophy typically involves discontinuing or changing the offending drug, if possible. Other treatments may include [[liposuction]], [[plastic surgery]], and management of metabolic complications. | Treatment for drug-induced lipodystrophy typically involves discontinuing or changing the offending drug, if possible. Other treatments may include [[liposuction]], [[plastic surgery]], and management of metabolic complications. | ||
== See also == | == See also == | ||
* [[Lipodystrophy]] | * [[Lipodystrophy]] | ||
| Line 18: | Line 31: | ||
* [[Insulin resistance]] | * [[Insulin resistance]] | ||
* [[Dyslipidemia]] | * [[Dyslipidemia]] | ||
[[Category:Drug-induced diseases]] | [[Category:Drug-induced diseases]] | ||
[[Category:Lipodystrophies]] | [[Category:Lipodystrophies]] | ||
[[Category:Endocrine diseases]] | [[Category:Endocrine diseases]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
{{No image}} | |||
{{No image}} | |||
Latest revision as of 06:01, 4 April 2025
| Drug-induced lipodystrophy | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fat redistribution, insulin resistance, dyslipidemia |
| Complications | Cardiovascular disease, diabetes mellitus |
| Onset | Varies depending on drug exposure |
| Duration | May be reversible upon discontinuation of the drug |
| Types | N/A |
| Causes | Antiretroviral therapy, glucocorticoids, anabolic steroids |
| Risks | Long-term use of certain medications |
| Diagnosis | Clinical evaluation, medical history, physical examination |
| Differential diagnosis | Congenital lipodystrophy, acquired lipodystrophy |
| Prevention | Monitoring and adjusting medication regimens |
| Treatment | Discontinuation or substitution of the causative drug, dietary management, exercise, metformin |
| Medication | N/A |
| Prognosis | Variable, depends on the ability to manage underlying causes |
| Frequency | Common in patients on long-term antiretroviral therapy |
| Deaths | N/A |
Drug-induced lipodystrophy is a medical condition characterized by abnormal or degenerative conditions of the body's adipose tissue. A side effect of some pharmaceutical drugs, it is a form of lipodystrophy and can be a significant adverse effect of treatment.
Causes[edit]
Drug-induced lipodystrophy can be caused by a number of drugs. These include insulin, protease inhibitors, glucocorticoids, and growth hormone therapy. The condition is most commonly associated with antiretroviral therapy for HIV.
Symptoms[edit]
The symptoms of drug-induced lipodystrophy can vary depending on the specific drug and the individual patient. However, common symptoms include lipoatrophy (loss of subcutaneous fat), lipohypertrophy (gain of subcutaneous fat), and metabolic complications such as insulin resistance, dyslipidemia, and diabetes mellitus.
Diagnosis[edit]
Diagnosis of drug-induced lipodystrophy is primarily based on the patient's medical history and physical examination. Laboratory tests may be used to confirm the diagnosis and assess the severity of the condition.
Treatment[edit]
Treatment for drug-induced lipodystrophy typically involves discontinuing or changing the offending drug, if possible. Other treatments may include liposuction, plastic surgery, and management of metabolic complications.
